Note 12 - Segment and Geographic Information

3 Months Ended

Mar. 31, 2014

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

12. Segment and Geographic Information

The Company has one reportable operating segment, the results of which are disclosed in the accompanying unaudited condensed consolidated financial statements.

Product revenue by product group is as follows:

	Three Months Ended March 31,
	2014		2013
Orthobiologics	$	11,572,150	$	11,283,547
Dermal		188,651		241,584
Surgical		1,752,020		988,864
Ophthalmic		208,584		928,458
Veterinary		630,000		1,052,036
Product revenue	$	14,351,405	$	14,494,489

Total revenue by geographic location in total and as a percentage of total revenue, for the three months ended March 31, 2014 and 2013 are as follows (prior period numbers have been reclassified to conform to current period presentation):

	Three Months Ended March 31,
	2014					2013
	Revenue		Percentage of Revenue			Revenue		Percentage of Revenue
Geographic Location:
United States	$	31,533,817		93	%	$	12,280,079		80	%
Europe		1,695,816		5	%		1,583,993		11	%
Other		780,654		2	%		1,382,939		9	%
Total revenue	$	34,010,287		100	%	$	15,247,011		100	%